Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Gross Profit Over TimeContracting
Percentile Rank33
3Y CAGR-5.4%
5Y CAGR-7.2%
Year-over-Year Change
Revenue minus cost of goods sold
3Y CAGR
-5.4%/yr
vs -21.2%/yr prior
5Y CAGR
-7.2%/yr
Consistent
Acceleration
+15.7pp
Accelerating
Percentile
P33
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $66.98M | +10.3% |
| 2025 | $60.74M | -10.2% |
| 2024 | $67.64M | -14.6% |
| 2023 | $79.20M | -8.1% |
| 2022 | $86.16M | -11.2% |
| 2021 | $97.07M | -20.7% |
| 2020 | $122.47M | -40.3% |
| 2019 | $205.20M | -0.7% |
| 2018 | $206.63M | +101.0% |
| 2017 | $102.81M | - |